Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disco-interacting protein 2 homolog C (DIP2C) is a human protein sharing strong homology with the Drosophila disco-interacting protein 2, which interacts with the transcription factor disco and is expressed in the nervous system. In humans, DIP2C is implicated as a versatile regulator in cancer biology (tumor suppression, DNA methylation, epithelial–mesenchymal transition), neurodevelopment (variants associated with autism, intellectual disability, epilepsy), and cardiovascular function (circRNA form protects endothelial cells), as well as metabolic pathways (uric acid regulation) and environmental responses. While including recurrent somatic mutations in cancer and loss-of-function variants linked to neurodevelopmental disorders, DIP2C does not currently serve as a direct pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disco-interacting protein 2 homolog C (DIP2C).